BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1786194)

  • 21. Postoperative adjuvant immunochemotherapy with mitomycin C, tegafur, PSK and/or OK-432 for gastric cancer, with special reference to the change in stimulation index after gastrectomy.
    Hattori T; Nakajima T; Nakazato H; Tanabe T; Kikuchi K; Abe O; Kondo T; Taguchi T; Komi N; Sugimachi K
    Jpn J Surg; 1990 Mar; 20(2):127-36. PubMed ID: 2111414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [S-1/krestin immunochemotherapy for patients with advanced gastric cancer].
    Aoyama T; Yoshikawa T; Hayashi T; Kuwabara H; Mikayama Y; Ogata T; Cho H; Tsuburaya A; Rino Y; Masuda M
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):1921-3. PubMed ID: 22202239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect and distribution of a protein-bound polysaccharide preparation, PSK (Krestin), intratumorally injected prior to surgery into gastric cancer patients.
    Tomochika H; Gouchi A; Okanobu K; Sasaki A; Fuchimoto S; Orita K
    Acta Med Okayama; 1989 Oct; 43(5):289-97. PubMed ID: 2610006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer.
    Nio Y; Tsubono M; Tseng CC; Morimoto H; Kawabata K; Masai Y; Shiraishi T; Imai S; Ohgaki K; Tobe T
    Biotherapy; 1992; 4(2):117-28. PubMed ID: 1622733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up.
    Ito K; Nakazato H; Koike A; Takagi H; Saji S; Baba S; Mai M; Sakamoto J; Ohashi Y;
    Int J Colorectal Dis; 2004 Mar; 19(2):157-64. PubMed ID: 13680286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical study of PSK as an adjuvant immunochemotherapeutic agent against gastric cancer].
    Mitomi T; Kyoji-Ogoshi
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2532-7. PubMed ID: 3090939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of far-advanced gastric cancer successfully treated with S-1/paclitaxel/krestin immunochemotherapy, followed by curative resection].
    Muguruma K; Tanaka H; Sakurai K; Kimura K; Nagahara H; Amano R; Noda E; Kubo N; Maeda K; Sawada T; Ohira M; Hirakawa K
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1770-2. PubMed ID: 23267881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa).
    Mitomi T; Tsuchiya S; Iijima N; Aso K; Suzuki K; Nishiyama K; Amano T; Takahashi T; Murayama N; Oka H
    Dis Colon Rectum; 1992 Feb; 35(2):123-30. PubMed ID: 1735313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of a combined application of radiotherapy, carboquone, and PSK in malignant tumor--clinical results at 7 facilities].
    Tsuya A; Kaneda K; Mikuriya S; Horiuchi J; Amino S; Mochizuki S; Kamata R; Ikeda M; Okawa T
    Gan No Rinsho; 1982; 28(1):49-54. PubMed ID: 7182548
    [No Abstract]   [Full Text] [Related]  

  • 30. PSK may suppress CD57(+) T cells to improve survival of advanced gastric cancer patients.
    Akagi J; Baba H
    Int J Clin Oncol; 2010 Apr; 15(2):145-52. PubMed ID: 20229169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum].
    Mitomi T; Tsuchiya S; Iijima N; Aso K; Suzuki K; Nishiyama K; Amano T; Takahashi T; Murayama N; Oka H
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2241-9. PubMed ID: 2500070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer.
    Iino Y; Yokoe T; Maemura M; Horiguchi J; Takei H; Ohwada S; Morishita Y
    Anticancer Res; 1995; 15(6B):2907-11. PubMed ID: 8669887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-operative long-term adjuvant immunochemotherapy with mitomycin-C, PSK and FT-207 in gastric cancer patients.
    Hattori T; Niimoto M; Koh T; Nakano A; Oride M; Takiyama W; Nishimawari K
    Jpn J Surg; 1979 Jun; 9(2):110-7. PubMed ID: 376911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK.
    Sakamoto J; Koike A; Saji S; Teramukai S; Ohashi Y; Nakazato H
    Surg Today; 1992; 22(6):530-6. PubMed ID: 1472793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of alternating administration of PS-K and carbazilquinone in tumor-bearing mice.
    Kondo T; Sakamoto J; Ichihashi H; Kamei H
    Gan; 1981 Apr; 72(2):293-9. PubMed ID: 7286551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer (II)].
    Tamada R; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Abe O; Kikuchi K; Tanabe T; Nakajima T
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):716-22. PubMed ID: 3103540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined effect of prophylactic lymphadenectomy and long term combination chemotherapy for curatively resected carcinoma of the stomach.
    Kodama Y; Kano T; Tamada R; Kumashiro R; Okamura T; Inokuchi K
    Jpn J Surg; 1982; 12(4):244-8. PubMed ID: 6811786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative CEA and PPD values as prognostic factors for immunochemotherapy using PSK and 5-FU.
    Takahashi Y; Mai M; Nakazato H
    Anticancer Res; 2005; 25(2B):1377-84. PubMed ID: 15865094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of adjuvant immunochemotherapy in advanced gastric cancer].
    Sakamoto J; Nakazato H
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2525-30. PubMed ID: 8279851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count.
    Toge T; Yamaguchi Y
    Oncol Rep; 2000; 7(5):1157-61. PubMed ID: 10948356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.